Table 1. Clinical and biochemical characteristics of the study cohort grouped as males and females.
All participants (n = 17735) | Males (n = 10596) | Females (n = 7139) | |
---|---|---|---|
UA (mmol/L) | 330.57 ± 94.03 | 374.80 ± 82.76 | 263.79 ± 66.62 |
BMD (g/cm2) | 1.12 ± 0.17 | 1.14 ± 0.15 | 1.10 ± 0.18 |
T-score | −0.62 ± 1.42 | −0.47 ± 1.36 | −0.84 ± 1.50 |
Z-score | 0.14 ± 1.34 | 0.04 ± 1.44 | 0.29 ± 1.17 |
Age (years) | 49.62 ± 10.46 | 49.38 ± 11.13 | 49.98 ± 10.80 |
Height (cm) | 164.06 ± 8.20 | 168.61 ± 6.29 | 157.31 ± 5.65 |
Weight (kg) | 65.48 ± 11.30 | 70.63 ± 10.09 | 57.84 ± 8.28 |
BMI (kg/m2) | 24.23 ± 3.14 | 24.81 ± 2.99 | 23.38 ± 3.16 |
Systolic BP (mmHg) | 123.42 ± 16.31 | 125.00 ± 15.39 | 120.81 ± 12.29 |
Glucose (mmol/L) | 5.56 ± 1.41 | 5.65 ± 1.15 | 5.44 ± 1.22 |
Serum calcium (mmol/L) | 2.36 ± 0.13 | 2.37 ± 0.13 | 2.35 ± 0.13 |
Serum phosphate(mmol/L) | 1.11 ± 0.17 | 1.08 ± 0.17 | 1.17 ± 0.16 |
Alkaline phosphatase (U/L) | 74.25 ± 21.85 | 75.98 ± 19.95 | 71.63 ± 24.21 |
AST (U/L) | 25.30 ± 18.65 | 26.79 ± 21.19 | 23.06 ± 13.65 |
ALT (U/L) | 29.08 ± 36.84 | 34.13 ± 42.59 | 21.44 ± 23.88 |
Triglycerides (mmol/L) | 1.78 ± 1.48 | 2.04 ± 1.64 | 1.39 ± 1.07 |
Total cholesterol (mmol/L) | 5.08 ± 0.98 | 5.09 ± 0.97 | 5.07 ± 0.99 |
Serum urea nitrogen (mmol/L) | 5.16 ± 1.34 | 5.35 ± 1.31 | 4.88 ± 1.33 |
Serum creatinine (μmol/L) | 77.85 ± 18.95 | 85.14 ± 15.22 | 66.85 ± 18.73 |
Total bilirubin (μmol/L) | 13.67 ± 5.87 | 14.61 ± 6.25 | 12.24 ± 4.92 |
Total protein (g/L) | 76.20 ± 4.39 | 75.96 ± 4.34 | 76.58 ± 4.44 |
eGFR (mL/min/1.73m2) | 90.41 ± 17.93 | 90.60 ± 16.13 | 90.12 ± 20.34 |
UA, uric acid; BP, blood pressure; AST, aspartate transaminase; ALT, alanine aminotransferase; BMD, bone mineral density; eGFR, estimated glomerular filtration rate.